Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

BlackRock Commentary: Brighter backdrop for emerging assets

Wei Li – Global Chief Investment Strategist of BlackRock investment institute, together with Alex Brazier – Deputy Head, Ben Powell – Chief Investment Strategist for APAC, and Axel Christensen- Chief Investment Strategist for LatAm & Iberia all forming part of the BlackRock Investment Institute, share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.

Key Points

Emerging markets: Emerging markets have weathered tightening financial conditions. We now see a relatively good backdrop for EM assets as EM rates peak and China reopens.

Market backdrop: Stocks added to gains and bond yields fell as markets priced in Federal Reserve rate cuts later in 2023. We don’t think inflation will cool enough to allow for cuts.

Week ahead: China GDP data due this week are unlikely to capture the rapid reopening that’s underway. The Bank of Japan could surprise with policy changes.

Emerging markets (EM) have weathered rapid rate hikes in developed markets (DM). Central banks were ahead of DM peers in tightening, and high commodity prices helped EM producers. We see the backdrop for EM assets turning more positive as EM rates peak, DM central banks pause, the U.S. dollar weakens and China reopens. By contrast, the damage of higher rates has yet to fully materialize in DM. We prefer selected EM equities and bonds over DM peers as a result.

Relative retreat

EM economies proved resilient to what should have been a big hit from tightening global financial conditions as the Fed embarked on the fastest hiking cycle since the 1980s. We see several reasons why. EM external balances have improved, central banks were ahead of DM in policy tightening, and higher commodity prices limited the fallout. Yet EM equities have underperformed DM peers – down nearly 20% since mid-2021 (orange line), when many EM central banks began to tighten policy. This slump might be warranted if there were some systemic risk for EM looming – but we don’t see that now. We think the long EM stock slide and recent rally show a lot of economic damage is now in the price as the EM backdrop turns more supportive. The U.S. dollar’s retreat (yellow line) and China’s reopening rally also helped EM assets in recent months.

We think the backdrop will turn more positive for EM, building on recent resilience. EM generally has higher levels of currency reserves, smaller current account deficits, improved external balances and better debt maturity mixes than they did in past DM tightening cycles that sparked volatility. The weaker links among EM are small and not a broader threat, in our view. We think this all helped EM avoid a “taper tantrum”-type investor flight when global financial conditions tightened. In fact, investors favored EM: our data shows inflows into EM equity exchange-traded funds hit a record in 2022.

We also see slowing tightening cycles in EM. Some EM central banks were as much as a year ahead of DM in hiking rates to combat inflation. We expect some divergence – inflation expectations in Brazil are declining, but the energy crunch in Europe is likely to keep inflation pressures higher in the EM countries of the continent. We see DM central banks pausing as the economic damage of their tightening becomes clearer – and as inflation cools from highs but still stays above pre-Covid levels. A pause in the Fed’s rate hikes would likely help spur a further retreat in the U.S. dollar. The risk? Markets have been pricing in Fed rate cuts later this year – something we don’t expect to happen given persistent inflation.

China’s reopening also brightens the view on EM as domestic demand restarts. Chinese assets represent a sizable share of EM indexes, so we see overall EM as a beneficiary of the reopening. Rising Chinese demand is likely to benefit other EM exporters with strong ties to China as growth rebounds, too. We estimate China’s economic growth will be above 6% in 2023, but it will be tempered by falling exports as goods demand cools with spending shifts in developed economies away from goods and toward services. That makes consumer spending and business investment even more critical in gauging how strong China’s recovery can be. We prefer Chinese assets to DM peers as well. Structural risks including an aging population and geopolitical tensions with the U.S. persist, but a strong rally in risk assets since October is becoming harder for some tactical investors to ignore.

Our bottom line

We see a more positive EM backdrop as DM central banks pause, the dollar weakens and China reopens. We take a selective approach across EM – with a wide range of factors at play, from external balances to idiosyncratic sovereign risk. We prefer EM over DM stocks – we think more damage is in the price from earlier hiking cycles. We’re neutral EM debt due to higher commodity prices and prefer it over long-term DM government bonds. Long-term DM yields don’t reflect the term premium, or compensation for risk, we think investors will demand in this regime of higher macro volatility.

Market backdrop

Global stocks added to gains this month, with European shares leading the way. U.S. Treasury yields retreated further, while the U.S. dollar index hit seven-month lows. The market is still pricing in Fed rate cuts later this year as inflation cools, as reflected in last week’s CPI. We think inflation will come down a lot this year – but not enough for the Fed to cut rates. We see the Fed pausing rate hikes once the damage from its policy overtightening is clear and then staying on hold

Week Ahead

Jan. 17: China GDP, retail sales, unemployment; UK jobs data

Jan. 18: UK  CPI; Bank of Japan policy decision

Jan. 19: U.S. housing starts; Japan CPI

Jan. 20: U.S. existing home sales

BlackRock’s Key risks & Disclaimers:

This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of 17th January, 2023 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.

The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets.

Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.

MeDirect Disclaimers:

This information has been accurately reproduced, as received from  BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Staying dynamic in our strategic views
All News

BlackRock Commentary: Staying dynamic in our strategic views

BlackRock anticipates that the new macroeconomic environment, characterized by increased volatility, will lead to more frequent valuation changes across asset classes. While short-term outcomes may not always be influenced by valuations, they remain significant in the long run.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 

Sign up and open your account for free, within minutes.



We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.